ASTHMA CONTROL COST-UTILITY RANDOMIZED TRIAL EVALUATION.

Recruiting

• Conditions: Asthma

• Registration Number: NL-OMON22219
• Lead Sponsor: -

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 720

Inclusion Criteria

1. Age 18-50 yr;

2. Doctors diagnosis of asthma;

Exclusion Criteria

1. Daily or alternate day oral corticosteroid therapy within 1 month before entering the study;

2. Inability to understand written or oral Dutch instructions;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pharmaco-economics:<br /><br>1. Net health benefit;<br /><br>2. Cost-effectiveness;<br /><br>3. Cost-utility.<br>

Secondary Outcome Measures

Name	Time	Method
1. Patient preferences; <br /><br>2. Compliance;<br /><br>3. Asthma related quality of life; <br /><br>4. The number of limited activity days; <br /><br>5. Exacerbations;<br /><br><br /><br /><br>Preplanned subgroupanalyses:<br /><br>1. Smokers vs. Non-smokers;<br /><br>2. Asthma control at baseline subdivided into strict, partly, or uncontrolled by Juniper Asthma Control Questionnaire scores of respectively <0.75, 0.75-1.5, >1.5 (Juniper et al. Resp.Med.2006);<br /><br>3. Exhaled Nitric Oxide status at baseline, subdivided into low(<25), medium(25-50) and high(>50));<br /><br>4. Allergic vs. non-allergic Asthma;<br /><br>5. BMI < 30 vs BMI > 30.